Genu Varum, Change of Direction, and Reactive Agility in Youth Football Players

September 2, 2026 updated by: Akdeniz University

Does Genu Varum Influence Change of Direction and Reactive Agility Performance in Youth Football Players?

The goal of this observational study is to compare change-of-direction (COD) and reactive agility (RA) performance between football players with and without genu varum and to examine whether lower-limb alignment is associated with these performance measures.

The main questions it aims to answer are:

  1. Do football players with and without genu varum differ in COD and RA performance?
  2. Is lower-limb alignment associated with COD and RA performance in football players with and without genu varum?

Football players with and without genu varum will undergo assessments of lower-limb alignment, COD performance, and RA performance. The study will compare performance between the two groups and examine the relationship between lower-limb alignment and performance measures.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study population consisted of male youth football players recruited from the academy of a professional football club based in Antalya, Türkiye. The football club competes in the Turkish Süper Lig, the highest tier of professional football in Türkiye.

Description

Inclusion Criteria:

  • At least five years of football experience
  • Participation in football training at least five days per week
  • Voluntary participation in the study

Exclusion Criteria:

  • History of lower extremity surgery
  • Current musculoskeletal injury affecting performance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Genu Varum Group
Football players with genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.
Control Group
Football players without genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change-of-direction performance
Time Frame: at basline
Change-of-direction performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). The test consists of a 14.5-m running course with four changes of direction. Performance will be evaluated based on total completion time, with lower times indicating better change-of-direction performance.
at basline
Reactive agility performance
Time Frame: at basline
Reactive agility performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). Participants will respond as quickly and accurately as possible to randomly presented visual stimuli and perform the required directional movements. Performance will be evaluated based on total completion time, with lower times indicating better reactive agility performance.
at basline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intercondylar distance and intermalleolar distance
Time Frame: at basline
Lower-limb alignment will be assessed by measuring intercondylar distance (ICD) and intermalleolar distance (IMD) in centimeters. ICD will be measured as the distance between the medial femoral condyles, and IMD as the distance between the medial malleoli, using a standardized measurement procedure.
at basline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 12, 2025

Study Registration Dates

First Submitted

August 28, 2026

First Submitted That Met QC Criteria

August 28, 2026

First Posted (Actual)

September 1, 2026

Study Record Updates

Last Update Posted (Actual)

September 3, 2026

Last Update Submitted That Met QC Criteria

September 2, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe